The 2nd
Diabetes Innovation Summit
for HCPs
You are invited to be a part of the distinctive future of Diabetes
The Second Diabetes Innovation Summit for Healthcare Professionals in Central & Eastern Europe, Middle East & Africa
January 26 & 27, 2024 Istanbul, Türkiye
Location
The event will take place in Sheraton Istanbul Ataköy Hotel. One of the largest metropols in the world, İstanbul is a strategical intersection point for almost everything. This distinctive city is one of the best options to host distinctive people at a special event.
Why Distinct?
We are the global healthcare technology leader, with more than 90,000 people across 150 countries. We innovate solutions that treat more than 70 health conditions, from Parkinson’s to diabetes. And while our healthcare technologies transform the lives of two people every second, every hour, of every day, expect more from us. We keep expanding our impact far beyond. In everything we do, we are engineering the extraordinary.
The rich history of diabetes within Medtronic is a distinctive story itself. This event will host the most distinctive healthcare professionals with the most innovative content. As this is the second Diabetes Innovation Summit organized by Medtronic, we are already thrilled to be sharing knowledge and expanding the opportunities about the future of diabetes. This extraordinary event needed an extraordinary name to tell its story.
Extraordinary evolution in Medtronic Diabetes technology
Get to know our faculty of speakers
World-class elite speakers will share their knowledge during Distinct 2024
- Senior consultant at the Department of pediatrics, The hospital of Halland – Kungsbacka, Sweden.
- Senior consultant at the Institution of clinical sciences, Sahlgrenska Academy at the University of Gothenburg, Sweden
Mohammed Al-Sofiani
Riyadh, Saudi Arabia
- Assistant Professor, Division of Endocrinology. Kind Saud University, Riyadh, Saudi Arabia
- Insulin Pump Center, Dr Suliman Al Habib Medical Group-Al-Takhassusi Hospital, Riyadh, Saudi Arabia
- Adj. Assistant Professor, Division of Endocrinology, The Johns Hopkins University, USA
Tadej Battelino
Ljubljana, Slovenia
- Consultant and Head of Department of Endocrinology Diabetes & Metabolism, and Clinical Pharmacologist, UMC-UCH Ljubljana, Slovenia
- Head, Chair of Pediatrics, and Professor of Paediatrics at Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Katrien Benhalima
Leuven, Belgium
- She is staff-member of the department of Endocrinology at the University Hospital Gasthuisberg Leuven (Belgium) and assistant Professor at KU Leuven.
- She has a senior clinical research fellowship from the Flemish Research Council (FWO). Her research is focused on gestational diabetes, type 1 diabetes in pregnancy, pregnancy in women with a history of bariatric surgery and young adults with type 2 diabetes.
- She is the principal investigator of several large ongoing studies to prevent diabetes after a recent history of gestational diabetes and she is also the principal investigator of the CRISTAL trial, a large RCT to evaluate the efficacy and safety of the MiniMed 780 (Medtronic) closed-loop system in type 1 diabetes pregnancy.
- She won several awards for her research such as the rising star researcher award by Primary Care Diabetes Europe, the Dr. Karel-Lodewijk Verleysen award of the ‘Royal Academy of Medicine’ of Belgium, the Novo Nordisk award for Diabetology, The Belgian Endocrine Society award and the Joseph Hoet research award of the Diabetic Pregnancy Study Group (DPSG).
Maria Ida Buompensiere
Tolochenaz, Switzerland
- Principal Reimbursement Analyst, Medtronic Diabetes EMEA
Paola Cardano
Milan, Italy
- Principal Medical Scientific Liaison, Medtronic Clinical & Regulatory Solutions (MCRS)
Asma Deeb
Abu Dhabi, UAE
- Chair of the Pediatric Endocrinology Division at Sheikh Shakhbout Medical City (SSMC), Abu Dhabi, UAE.
- ASPED President
Klemen Dovč
Ljubljana Slovenia
- Attending Paediatric Endocrinologist at UMC Ljubljana University Children's Hospital, Ljubljana Slovenia
- Assistant professor at University of Ljubljana Faculty of Medicine
Nancy Elbarbary
Cairo, Egypt
- Professor of Pediatric Diabetes, Faculty of Medicine, Ain Shams University, Cairo, Egypt
- Consultant of Pediatric Diabetes and Chair Of Diabetes Research And Diabetes Guidelines Committee of ASPED
- Member of research and ethics committee at Ain Shams University hospitals, Cairo, Egypt
Federico Gavioli
Milan, Italy
- Senior Vice President Medtronic Diabetes EMEA & Americas
Mohamed Hassanein
Dubai, UAE
- Consultant in Diabetes & Endocrinology, Dubai Hospital, Dubai, UAE
- Professor of Medicine, Mohamed Bin-Rashid University, UAE
- Professor of Medicine, Gulf Medical University, UAE
- Associate Director, Post Graduate Diabetes Education, Cardiff University, Cardiff, UK
- Chair of DAR Diabetes and Ramadan (DAR) International Alliance
Majid Kaddoumi
Dubai, UAE
- Sr. Vice President & President, Medtronic EMEA RLM
Partha Kar
Portsmouth, United Kingdom
- Consultant in Diabetes and Endocrinology at Portsmouth Hospitals NHS Trust, UK
- National Specialty Advisor, Diabetes with NHS England and co-author of the national Diabetes GIRFT report
- Co-creator of TAD (Talking About Diabetes) – TED talks from those with T1Diabetes
- Co- creator of Type 1 Diabetes comic (Volume 1 to 4)
- Co-creator of DEVICES (Virtual Reality educational modules in diabetes)
Tomasz Klupa
Kraków, Poland
- Head of the Center for Advanced Technologies in Diabetes, Department and Chair of Metabolic Diseases Jagiellonian University Medical College, Kraków, Poland
- Leader of Medtronic Center of Reference (COR)
- Regional consultant of Diabetology in Małopolska district
- Head of the "Pump School" educational initiative of the Polish Diabetes Association
Louis Lintereur
Los Angeles, USA
- Senior Distinguished Chief Engineer, Automated Delivery Systems, Medtronic Diabetes USA
Goran Petrovski
Doha, Qatar
- Senior Attending Physician at Sidra Medicine, Doha, Qatar
Draženka Pongrac Barlovič
Ljubljana, Slovenia
- Attending Endocrinologist at Ljubljana University Medical Centre UMC, Department of Endocrinology, Diabetes and Metabolic Disease, Ljubljana, Slovenia
Abdullah Alguwaihes
Riyadh, Saudi Arabia
- Associate Professor of Medicine & Consultant Endocrine and Diabetes at College of Medicine and King Saudi University Medical City, King Saud University, Riyadh, Saudi Arabia
Delia Reurean-Pintilei
Iași, Romania
- Primary Doctor in Diabetes, Nutrition, Metabolic Diseases.
- Founder and Medical Director of Nutrition Clinic at The Medical Consultmed Center, Iași, Romania
Vittorino Smaniotto
Tolochenaz, Switzerland
- Senior Medical Affairs and Education Manager, Medtronic Diabetes EMEA
Anna-Kaisa Tuomaala
Helsinki, Finland
- Pediatric endocrinologist at Helsinki University Hospital, Helsinki, Finland
Jacobus Van Dyk
Pretoria, South Africa
- Paediatric Endocrinologist, Pretoria, South Africa
- Lecturer and elective training site director, Division of Endocrinology, Department of Pediatrics, University of Pretoria
- Chairman and founding member, Kids and Care SA (NGO for development of educational material to improve the care of diabetes in SA)
- Director, Paediatric and Adolescent Diabetes Centre, Life Groenkloof Hospital, Pretoria, South Africa
- Executive committee member, Paediatric Endocrine Society of South Africa (PAEDS-SA)
Liesbeth Van Huffel
Aalst, Belgium
- Endocrinologist at OLV Hospital Aalst, Belgium
Robert Vigersky
Washington, USA
- Chief Medical Officer, Global Medical and Clinical Affairs, Medtronic Diabetes, Minneapolis, USA
- Past-President, Endocrine Society
- Professor of Medicine, Uniformed Services University of the Health Sciences, Washington, DC, USA
Download the agenda
We know that in diabetes every minute counts.That’s why we designed a distinctive program to contribute to the efficiency of innovative learning.
Technology that transforms lives
Get to know Medtronic Diabetes therapies
MiniMed™ 780G system with SmartGuard™ technology.
Our most advanced insulin pump system with SmartGuard™ automation for
self-adjusting basal delivery with autocorrection dosing.
Now with Guardian™ 4 sensor.
New! Now compatible with Apple® Watch.
Medtronic infusion sets
and reservoir
for Insulin Pumps
Designed for everybody and every lifestyle.
- Medtronic’s wide range of infusion sets aims to provide patients with the possibility to select the right infusion set for their comfort and safety. This selection should be based on your lifestyle, age, body type, preferences and clinical recommendations.
- Medtronic Reservoirs are also available in 1.8 ml and 3.0 ml sizes in order to meet daily insulin needs.
Carelink™ system
Personalised patient outcomes.
- Designed to take information from Medtronic insulin pumps, Continuous Glucose Monitoring (CGM) devices and Blood Glucose (BG) meters, CareLink™ System provides insightful reports, allowing you to spend more time on helping your patients manage their diabetes.
- The portfolio of CareLink™ reports can identify trends, track daily activities and help you identify patterns and behaviour which may be affecting a patients diabetes management.
- With CareLink™ System, you have: exclusive access to patients insight reports, access to reports via web browsers on PC, Mac or iPad tablets and online access, whenever and wherever you like.
Smart MDI system
The Smart MDI systems combines the power of real time CGM with predictive glucose alerts and personalised insulin dosing to help your patients stay ahead of their glucose levels and take the right dose at the right time.6,7
- Predict Highs and lows up to 60 minutes in advance6,7
- Makes dosing easier for patients with a built-in insulin dose calculator
- Automatically† records both glucose levels and administered insulin with no fingerprick‡
- The Smart MDI system can help patients to take the right dose at the right time
i-Port Advance™
Let’s reduce the anxiety of injections together.8
- i-Port Advance is a subcutaneous injection port enabling the user to administer multiple daily injections.
- It can be worn for up to 72 hours¶ thus may reduce the number of skin punctures related to administration from an average of 4-6 per day to just one every 3 days. i-Port Advance is for patients who want to reduce the intrusion of injections on daily life.
References
1. Carlson AL, et al. Poster # 97 at the 80th International Conference of the American Diabetes Association, June 2020, Chicago/Virtual.
2. Medtronic data on file: Pivotal Trial (Age 14-75). N=157. 16 US sites; 2020.
3. Battelino T, et al. Diabetes Care 2019; 42(8): 1593-1603.
4. ADA Guidelines of A1C<7.0 – www.Diabetes.org
5. Bosi E, et al. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemiaprone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial. Lancet Diabetes Endocrinol 2019;7: 462–72.
6. Abraham SB, et al. Improved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts. Journal of Diabetes Science and Technology 2021; 15(1):91–97
7. Smith M, et al, E5 , SIPs Improve Time Below Range in MDI Therapy, AMCP Congress 2020
8. Riley D, Raup G. Impact of a subcutaneous injection device on improving patient care. Nurs Manage. 2010;41(6):49-54
* A blood glucose (BG) reading is needed when entering SmartGuard™ feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuard™ feature. Some user interaction required.
** Refer to MiniMed™ Mobile app User Guide
† Some user interaction required.
‡ If CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. Refer to System User Guide
¶ Do not inject more than 75 times through a single device. This information does not substitute the Instructions for Use/User Guide. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for use.